Skip to main content
ConductScienceScienceDex

Derin B Keskin

NIH Rank #3931
Unclaimed recordClaim profile
  • R01 Holder
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10881202Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology

NIH Funding · FY2025

Linked Award Amount
$2.8M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#3,931
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Derin B Keskin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Derin B Keskin as a PI. Multi-PI records show the full award amount for context.

  • 5R01HL157174-04R01
    Systematic identification of minor histocompatibility antigens to address GVHD
    Dana-Farber Cancer Institute
    $768.2K
    award amount
  • 5R01CA279391-02R01
    Merkel cell polyomavirus HLA class I epitopes for generating therapeutic T cell-based cancer immunotherapy
    Dana-Farber Cancer Institute
    $703.5K
    award amount
  • 5R01CA285308-03R01
    Genetically engineered mouse model to improve therapy of NUT carcinoma
    Brigham and Women's Hospital
    $657K
    award amount
  • 1R01NS140967-01R01
    Mechanisms of lmmunosuppression in MYCN-driven Neuroblastoma
    Boston University
    $635.2K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Derin B Keskin as a PI.

Dana-Farber Cancer Institute
MA
$1.5M
2 grants
Brigham and Women's Hospital
MA
$657K
1 grant
Boston University
MA
$635.2K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Dana-Farber Cancer Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4955
  6. 2024
    Entered Top 25% Nationally
    Ranked #4955
  7. 2025
    Multi-Institutional Research
    Awards at 3 institutions
  8. 2025
    R01 Grant Holder
  9. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Derin B Keskin.

Christopher A French
Brigham and Women's Hospital
2
shared awards
Geoffrey I. Shapiro
Brigham and Women's Hospital
2
shared awards
Hui Feng
Boston University
2
shared awards
Vincent Trien-vinh Ho
Dana-Farber Cancer Institute
2
shared awards
Catherine Ju-ying Wu
Dana-Farber Cancer Institute
1
shared award

Explore further

Find collaborators for Derin B Keskin

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →